Ovid Therapeutics logo

Ovid Therapeutics share price today

(OVID)

Ovid Therapeutics share price is $0.95 & ₹81.52 as on 7 Jan 2025, 2.30 'hrs' IST

$0.95

-0.01

(-1.39%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Ovid Therapeutics share price in Dollar and Rupees. Guide to invest in Ovid Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Ovid Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Ovid Therapeutics share price movements

  • Today's Low: $0.95
    Today's High: $1.00

    Day's Volatility :5.0%

  • 52 Weeks Low: $0.68
    52 Weeks High: $4.10

    52 Weeks Volatility :83.41%

Ovid Therapeutics Returns

PeriodOvid Therapeutics IncIndex (Russel 2000)
3 Months
-12.38%
0.0%
6 Months
16.13%
0.0%
1 Year
-69.79%
0.0%
3 Years
-69.5%
-19.8%

Ovid Therapeutics Key Statistics

in dollars & INR

Previous Close
$0.9638
Open
$0.9746
Today's High
$1.0
Today's Low
$0.95
Market Capitalization
$66.3M
Today's Volume
$173.5K
52 Week High
$4.1
52 Week Low
$0.68
Revenue TTM
$631.7K
EBITDA
$-65.1M
Earnings Per Share (EPS)
$-0.46
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-36.61%

How to invest in Ovid Therapeutics from India?

It is very easy for Indian residents to invest directly in Ovid Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ovid Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Ovid Therapeutics or OVID on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ovid Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ovid Therapeutics shares which would translate to 0.903 fractional shares of Ovid Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Ovid Therapeutics, in just a few clicks!

Returns in Ovid Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ovid Therapeutics investment value today

Current value as on today

₹33,003

Returns

₹66,997

(-67%)

Returns from Ovid Therapeutics Stock

₹70,219 (-70.22%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Ovid Therapeutics

24%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Ovid Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 24% more investors are searching Ovid Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Ovid Therapeutics

  • Rubric Capital Management LP

    7.49%

  • Madison Avenue Partners, LP

    5.80%

  • BlackRock Inc

    5.62%

  • Bvf Inc

    5.43%

  • Vanguard Group Inc

    4.43%

  • Siren, L.L.C.

    4.01%

Analyst Recommendation on Ovid Therapeutics

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Ovid Therapeutics(by analysts ranked 0 to 5 stars)

Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
11
11
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Ovid Therapeutics

What analysts predicted

Upside of 243.16%

Current:

$0.95

Target:

$3.26

Insights on Ovid Therapeutics

  • Price Movement

    In the last 1 month, OVID stock has moved down by -16.2%
  • Increasing Revenue

    Revenue is up for the last 9 quarters, 11.10K → 173.0K (in $), with an average increase of 23.9% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 8.52M → -14.00M (in $), with an average decrease of 264.4% per quarter
  • OVID vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 92.1%
  • OVID vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 126.1%
  • Price to Sales

    ForOVID every $1 of sales, investors are willing to pay $107.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Ovid Therapeutics Technicals Summary

Sell

Neutral

Buy

Ovid Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Ovid Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Ovid Therapeutics Inc
-17.62%
16.13%
-69.79%
-69.5%
-76.2%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Ovid Therapeutics Inc
NA
NA
0.0
-0.41
-0.37
-0.36
NA
1.07
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Ovid Therapeutics Inc
Buy
$66.3M
-76.2%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Ovid Therapeutics

ovid therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. ovid’s drug candidate, ov101, is currently in development for the treatment of symptoms of angelman syndrome and fragile x syndrome. ovid is also developing ov935 in collaboration with takeda pharmaceutical company limited for the treatment of rare epileptic encephalopathies. ovid has initiated the phase 2 stars trial of ov101 in adults with angelman syndrome and a phase 1 trial in adolescents with angelman and fragile x syndrome to identify doses suitable for younger patients. review our community guidelines: http://www.ovidrx.com/community-guidelines/
Organization
Ovid Therapeutics
Employees
25
CEO
Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.
Industry
Health Technology

Management People of Ovid Therapeutics

NameTitle
Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.
CEO & Chairman
Mr. Jeffrey A. Rona
Chief Business and Financial Officer
Ms. Meg Alexander
President & COO
Dr. Dirk Haasner
Senior Vice President of Global Manufacturing & CMC QA
Dr. Julia Tsai Ph.D.
Senior Vice President of Clinical Development
Dr. Toshiya Nishi D.V.M.
Head of Epilepsy Research
Mr. Zhong Zhong Ph.D.
Chief Scientific Officer
Mr. Tom Parry
Vice President of Research and Early Development
Garret Bonney
Investor Relations Officer

Important FAQs about investing in Ovid Therapeutics from India :

What is Ovid Therapeutics share price today?

Ovid Therapeutics share price today stands at $0.95, Open: $0.97 ; Previous Close: $0.96 ; High: $1.00 ; Low: $0.95 ; 52 Week High: $4.10 ; 52 Week Low: $0.68. The stock opens at $0.97, after a previous close of $0.96. The stock reached a daily high of $1.00 and a low of $0.95, with a 52-week high of $4.10 and a 52-week low of $0.68.

Can Indians buy Ovid Therapeutics shares?

Yes, Indians can invest in the Ovid Therapeutics (OVID) from India.

With INDmoney, you can buy Ovid Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Ovid Therapeutics at zero transaction cost.

How can I buy Ovid Therapeutics shares from India?

It is very easy to buy Ovid Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ovid Therapeutics be purchased?

Yes, you can buy fractional shares of Ovid Therapeutics with INDmoney app.

What are the documents required to start investing in Ovid Therapeutics stocks?

To start investing in Ovid Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Ovid Therapeutics

Today’s highest price of Ovid Therapeutics (OVID) is $1.00.

Today’s lowest price of Ovid Therapeutics (OVID) is $0.95.

What is today's market capitalisation of Ovid Therapeutics

Today's market capitalisation of Ovid Therapeutics OVID is 66.3M

What is the 52 Week High and Low Range of Ovid Therapeutics

  • 52 Week High

    $4.10

  • 52 Week Low

    $0.68

What are the historical returns of Ovid Therapeutics?

  • 1 Month Returns

    -17.62%

  • 3 Months Returns

    16.13%

  • 1 Year Returns

    -69.79%

  • 5 Years Returns

    -76.2%

Who is the Chief Executive Officer (CEO) of Ovid Therapeutics

Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D. is the current Chief Executive Officer (CEO) of Ovid Therapeutics.